Switzerland
· Delayed Price · Currency is CHF Cosmo Pharmaceuticals Statistics
Total Valuation
SWX:COPN has a market cap or net worth of CHF 914.46 million. The enterprise value is 788.75 million.
| Market Cap | 914.46M |
| Enterprise Value | 788.75M |
Important Dates
The next estimated earnings date is Wednesday, July 23, 2025.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Jun 4, 2025 |
Share Statistics
SWX:COPN has 16.02 million shares outstanding. The number of shares has increased by 1.94% in one year.
| Current Share Class | 16.02M |
| Shares Outstanding | 16.02M |
| Shares Change (YoY) | +1.94% |
| Shares Change (QoQ) | +3.31% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 16.99% |
| Float | 8.52M |
Valuation Ratios
The trailing PE ratio is 7.50 and the forward PE ratio is 19.20.
| PE Ratio | 7.50 |
| Forward PE | 19.20 |
| PS Ratio | 3.65 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | 6.17 |
| P/OCF Ratio | 6.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 5.33.
| EV / Earnings | 6.31 |
| EV / Sales | 3.15 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 5.65 |
| EV / FCF | 5.33 |
Financial Position
The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.19 |
| Quick Ratio | 3.39 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 2,809.10 |
Financial Efficiency
Return on equity (ROE) is 29.31% and return on invested capital (ROIC) is 20.39%.
| Return on Equity (ROE) | 29.31% |
| Return on Assets (ROA) | 15.87% |
| Return on Invested Capital (ROIC) | 20.39% |
| Return on Capital Employed (ROCE) | 24.88% |
| Revenue Per Employee | 777,307 |
| Profits Per Employee | 388,193 |
| Employee Count | 322 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 3.27 |
Taxes
In the past 12 months, SWX:COPN has paid 18.93 million in taxes.
| Income Tax | 18.93M |
| Effective Tax Rate | 13.16% |
Stock Price Statistics
The stock price has decreased by -18.48% in the last 52 weeks. The beta is 1.30, so SWX:COPN's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -18.48% |
| 50-Day Moving Average | 53.29 |
| 200-Day Moving Average | 62.04 |
| Relative Strength Index (RSI) | 53.07 |
| Average Volume (20 Days) | 23,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:COPN had revenue of CHF 250.29 million and earned 125.00 million in profits. Earnings per share was 7.61.
| Revenue | 250.29M |
| Gross Profit | 207.74M |
| Operating Income | 139.68M |
| Pretax Income | 143.88M |
| Net Income | 125.00M |
| EBITDA | 150.55M |
| EBIT | 139.68M |
| Earnings Per Share (EPS) | 7.61 |
Balance Sheet
The company has 134.12 million in cash and 2.06 million in debt, giving a net cash position of 132.06 million or 8.25 per share.
| Cash & Cash Equivalents | 134.12M |
| Total Debt | 2.06M |
| Net Cash | 132.06M |
| Net Cash Per Share | 8.25 |
| Equity (Book Value) | 473.86M |
| Book Value Per Share | 29.19 |
| Working Capital | 144.47M |
Cash Flow
In the last 12 months, operating cash flow was 152.37 million and capital expenditures -4.27 million, giving a free cash flow of 148.10 million.
| Operating Cash Flow | 152.37M |
| Capital Expenditures | -4.27M |
| Free Cash Flow | 148.10M |
| FCF Per Share | 9.25 |
Margins
Gross margin is 83.00%, with operating and profit margins of 55.81% and 49.94%.
| Gross Margin | 83.00% |
| Operating Margin | 55.81% |
| Pretax Margin | 57.49% |
| Profit Margin | 49.94% |
| EBITDA Margin | 60.15% |
| EBIT Margin | 55.81% |
| FCF Margin | 59.17% |
Dividends & Yields
This stock pays an annual dividend of 1.92, which amounts to a dividend yield of 3.29%.
| Dividend Per Share | 1.92 |
| Dividend Yield | 3.29% |
| Dividend Growth (YoY) | -1.09% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 24.09% |
| Buyback Yield | -1.94% |
| Shareholder Yield | 1.44% |
| Earnings Yield | 13.67% |
| FCF Yield | 16.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:COPN has an Altman Z-Score of 7.21 and a Piotroski F-Score of 8.
| Altman Z-Score | 7.21 |
| Piotroski F-Score | 8 |